BENDAMUSTINE IN COMBINATION WITH RITUXIMAB AS FIRST LINE THERAPY FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A RETROSPECTIVE REAL PRACTICE ITALIAN MULTICENTRE STUDY

被引：0

作者：

Gentile, M. ^{[1
]}

Ciolli, S. ^{[2
]}

Molica, S. ^{[3
]}

Di Renzo, N. ^{[4
]}

Selleri, C. ^{[5
]}

Villa, M. R. ^{[6
]}

De Paolis, M. R. ^{[4
]}

Scortechini, I. ^{[7
]}

Giannotta, A. ^{[8
]}

Minoia, C. ^{[9
]}

Boncompagni, R. ^{[2
]}

Bonanno, V. ^{[10
]}

Levato, L. ^{[3
]}

Musso, M. ^{[10
]}

Mastrullo, L. ^{[6
]}

Melpignano, A. ^{[8
]}

Murru, R. ^{[11
]}

Angelucci, E. ^{[11
]}

Caparrotti, G. ^{[1
,2
,12
]}

Guarini, A. ^{[1
,3
,13
]}

Pinto, A. ^{[1
,4
,14
]}

Ferrara, F. ^{[1
,5
,15
]}

Zinzani, P. ^{[1
,6
,16
]}

Morabito, F. ^{[1
,7
,17
]}

机构：

[1] UOC Ematol Cosenza, Cosenza, Italy

[2] Azienda Osped Univ Careggi, SODC Ematol, Florence, Italy

[3] Pugliese Ciaccio Hosp, Dept Oncol & Haematol, Catanzaro, Italy

[4] Osped Vito Fazzi, Hematol Unit, Lecce, Italy

[5] Univ Salerno, Hematol & SCT Transplant Ctr, Dept Med, AOU San Giovanni Dio & Ruggi Aragona, I-84100 Salerno, Italy

[6] UOC Ematol PO San Gennaro Napoli, Naples, Italy

[7] AO Osped Riuniti Marche, Div Ematol, Ancona, Italy

[8] Osped Antonio Perrino Brindisi, UOC Ematol, Brindisi, Italy

[9] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy

[10] UO Ematol & Trapianto Midollo Osseo La Maddalena, Palermo, Italy

[11] A Businco Cagliari, UO Ematol Osped Oncol, Cagliari, Italy

[12] PO G Moscati Aversa, UO Ematol, Aversa, Italy

[13] IRCCS Ist Tumori Giovanni Paolo II Bari, UOC Ematol, Bari, Italy

[14] IRCCS Fdn G Pascale Napoli, SC Ematol Oncol INT, Naples, Italy

[15] Osped Cardarelli Napoli, Div Ematol, Naples, Italy

[16] L&A Seragnoli Bologna, Inst Hematol & Med Oncol, Bologna, Italy

[17] UOC Ematol Cosenza, Cosenza, Italy

来源：

HAEMATOLOGICA | 2014年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PB1503

引用

页码：584 / 584

页数：1

共 50 条

[41] Bendamustine with Rituximab Is Safe and Effective As FRONT LINE Therapy in Elderly B-CLL Patients. an ITALIAN RETROSPECTIVE MULTICENTER Experience
Laurenti, Luca
Autore, Francesco
Innocenti, Idanna
Vannata, Barbara
Cantonetti, Maria
Del Principe, Maria Ilaria
Mauro, Francesca Romana
Paola, Anticoli Borza
Bongarzoni, Velia
Ciolli, Stefania
Boncompagni, Riccardo
Sciume, Mariarita
Vincenti, Daniele
Ghio, Francesco
Cecconi, Nadia
Pitini, Vincenzo
Mondello, Patrizia
Cariccio, Maria Rosa Lanza
Gozzetti, Alessandro
D'Arena, Giovanni
Murru, Roberta
Piccirillo, Nicola
Petrini, Mario
Cortelezzi, Agostino
Del Poeta, Giovanni
Foa, Robin
Sica, Simona
BLOOD, 2014, 124 (21)
[42] COST-EFFECTIVENESS OF BENDAMUSTINE VERSUS FLUDARABINE FOR FIRST LINE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN COLOMBIA
Bertwistle, D.
Munakata, J.
Wehler, E.
Leyva, V
Ariza, J. G.
Zambrano, C.
Gonzalez, L.
VALUE IN HEALTH, 2013, 16 (07) : A413 - A413
[43] Fludarabine, cyclophosphamide and rituximab (FCR) in front line treatment of patients with chronic lymphocytic leukemia (CLL)
Grifi, Fatiha
Bougherira, Soraya
Djenouni, Amel
LEUKEMIA & LYMPHOMA, 2017, 58 : 94 - 94
[44] Observational study in comorbid patients with CLL receiving first-line rituximab-bendamustine
Spacek, Martin
Doubek, Michael
Obrtlikova, Petra
Novak, Jan
Trneny, Marek
Hadrabova, Marketa
Cmunt, Eduard
Karban, Josef
Molinsky, Jan
Simkovic, Martin
Mocikova, Heidi
Smolej, Lukas
Panovska, Anna
Mohammadova, Lekaa
LEUKEMIA & LYMPHOMA, 2017, 58 : 119 - 120
[45] Efficacy and Safety Of Bendamustine In Combination With Rituximab For Elderly Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia. A Retrospective Multicenter Study
Laurenti, Luca
Vannata, Barbara
Innocenti, Idanna
Autore, Francesco
Ghio, Francesco
Cecconi, Nadia
Pitini, Vincenzo
Mondello, Patrizia
Lanza Cariccio, Maria Rosa
Gozzetti, Alessandro
D'Arena, Giovanni
Murru, Roberta
Piccirillo, Nicola
Leone, Giuseppe
Sica, Simona
BLOOD, 2013, 122 (21)
[46] Ibrutinib As First Line Therapy in Chronic Lymphocytic Leukemia Patients over 80 Years Old: A Retrospective Real-Life Multicenter Italian Cohort
Martino, Enrica Antonia
Mauro, Francesca Romana
Reda, Gianluigi
Laurenti, Luca
Visentin, Andrea
Frustaci, Annamaria
Vigna, Ernesto
Pepe, Sara
Catania, Gioacchino
Loseto, Giacomo
Murru, Roberta
Chiarenza, Annalisa
Sportoletti, Paolo
Del Principe, Maria Ilaria
Coscia, Marta
Galimberti, Sara
Tedeschi, Alessandra
Rossi, Davide
Trentin, Livio
Morabito, Fortunato
Gattei, Valter
Gentile, Massimo
BLOOD, 2023, 142
[47] Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real-life multicenter Italian cohort
Martino, Enrica Antonia
Mauro, Francesca Romana
Reda, Gianluigi
Laurenti, Luca
Visentin, Andrea
Frustaci, Annamaria
Vigna, Ernesto
Pepe, Sara
Catania, Gioacchino
Loseto, Giacomo
Murru, Roberta
Chiarenza, Annalisa
Sportoletti, Paolo
Del Principe, Maria Ilaria
Laureana, Roberta
Coscia, Marta
Galimberti, Sara
Ferretti, Eleonora
Zucchetto, Antonella
Bomben, Riccardo
Polesel, Jerry
Tedeschi, Alessandra
Rossi, Davide
Trentin, Livio
Neri, Antonino
Morabito, Fortunato
Gattei, Valter
Gentile, Massimo
HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
[48] Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study
Cuneo, Antonio
Follows, George
Rigolin, Gian Matteo
Piciocchi, Alfonso
Tedeschi, Alessandra
Trentin, Livio
Medina Perez, Angeles
Coscia, Marta
Laurenti, Luca
Musuraca, Gerardo
Farina, Lucia
Rivas Delgado, Alfredo
Orlandi, Ester Maria
Galieni, Piero
Mauro, Francesca Romana
Visco, Carlo
Amendola, Angela
Billio, Atto
Marasca, Roberto
Chiarenza, Annalisa
Meneghini, Vittorio
Ilariucci, Fiorella
Marchetti, Monia
Molica, Stefano
Re, Francesca
Gaidano, Gianluca
Gonzalez, Marcos
Forconi, Francesco
Ciolli, Stefania
Cortelezzi, Agostino
Montillo, Marco
Smolej, Lukas
Schuh, Anna
Eyre, Toby A.
Kennedy, Ben
Bowles, Kris M.
Vignetti, Marco
de la Seam, Javier
Moreno, Carol
Foa, Robin
Ghia, Paolo
HAEMATOLOGICA, 2018, 103 (07) : 1209 - 1217
[49] RITUXIMAB PLUS BENDAMUSTINE IN ELDERLY PATIENTS AFFECTED BY RELAPSED OR REFRACTORY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Lucania, A.
Villa, M. R.
Izzo, G. Nitrato
Improta, S.
Mastrullo, L.
HAEMATOLOGICA, 2014, 99 : 591 - 591
[50] Combination of bendamustine and rituximab as frontline therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
Gentile, Massimo
Zirlik, Katja
Ciolli, Stefania
Mauro, Francesca R.
Di Renzo, Nicola
Mastrullo, Lucia
Angrilli, Francesco
Molica, Stefano
Tripepi, Giovanni
Giordano, Annamaria
Di Raimondo, Francesco
Selleri, Carmine
Coscia, Marta
Musso, Maurizio
Orsucci, Lorella
Mannina, Donato
Rago, Angela
Giannotta, Angela
Ferrara, Felicetto
Herishanu, Yair
Shvidel, Lev
Tadmor, Tamar
Scortechini, Ilaria
Ilariucci, Fiorella
Murru, Roberta
Guarini, Attilio
Musuraca, Gerardo
Mineo, Giuseppe
Vincelli, Iolanda
Arcari, Annalisa
Tarantini, Giuseppe
Caparrotti, Giuseppe
Chiarenza, Annalisa
Levato, Luciano
Villa, Maria Rosaria
De Paolis, Maria Rosaria
Zinzani, Pier Luigi
Polliack, Aaron
Morabito, Fortunato
EUROPEAN JOURNAL OF CANCER, 2016, 60 : 154 - 165

← 1 2 3 4 5 →